Volume 20, Number 3—March 2014
Research
Neisseria meningitidis Serogroup W, Burkina Faso, 2012
Table 2
Variable | Prevaccine |
Postvaccine |
|||||
---|---|---|---|---|---|---|---|
2007 | 2008 | 2009 | 2010 | 2011 | 2012 | ||
Total no. cases reported in MPE | NA | NA | NA | 3,413 | 3,415 | 5,807 | |
Total no. specimens tested in aggregated laboratory results | 550 | 93 | 241 | NA | NA | NA | |
Confirmed or probable cases, no. | 286 | 52 | 139† | 1,408 | 1,306 | 2,768 | |
Neisseria meningitidis, no. cases (Incidence): | 257 (1.8) | 49 (0.3) | 43 (0.3) | 170 (1.1) | 278 (1.7) | 1,788 (10.7) | |
N. meningitidis serogroup W, no. cases (Incidence): |
4 (<0.1) |
0 |
4 (<0.1) |
10 (<0.1) |
113 (0.7) |
1,451 (8.7) |
|
Total cases reported in TLOH | 25,695 | 10,345 | 4,878 | 6,837 | 3,878 | 7,022 |
*Incidence = cases per 100,000 population. MPE, Maladies à Potentiel Epidémique (case-based surveillance); NA, not available; TLOH, Télégramme Lettre Official Hebdomadaire (aggregate case counts).
†Only latex agglutination results available.
Page created: January 27, 2014
Page updated: January 27, 2014
Page reviewed: January 27, 2014
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.